NCT04664868 is a clinical trial of Sphinkeeper™ in Faecal Incontinence, sponsored by Medical University of Vienna.

Who is sponsoring NCT04664868?

NCT04664868 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04664868?

Interventions in NCT04664868: Sphinkeeper™.

What condition does NCT04664868 study?

NCT04664868 studies Faecal Incontinence.

Is NCT04664868 still recruiting?

NCT04664868 is currently completed. Last updated 11 December 2020.

Last reviewed 2020-12-11 · How we verify

NCT04664868

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SphinkeeperTM Procedure for Treating Severe Faecal Incontinence

Completed Last updated 11 December 2020

What this trial tests

trial testing Sphinkeeper™ in Faecal Incontinence in 11 participants. Completed in 1 July 2020.

Timeline

1 August 2018

Primary endpoint
1 November 2019

1 July 2020

Quick facts

Lead sponsor	Medical University of Vienna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	11
Start date	1 August 2018
Primary completion	1 November 2019
Estimated completion	1 July 2020
Sites	1 location across Austria

Drugs / interventions tested

Sphinkeeper™

Conditions studied

Faecal Incontinence — all drugs for Faecal Incontinence →

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 90, any sex, with Faecal Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients, aged 18 - 90 years, undergoing sphinkeeper operation at the Department of General Surgery at the Medical University of Vienna are enrolled into our study. Primary endpoints is the functional outcome as well as movement, migration and extrusion of sphinkeeper prostheses after implantation by endoluminal ultrasound and manometrical examination.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Sphinkeeper Procedure for Treating Severe Faecal Incontinence-A Prospective Cohort Study.
Dawoud C, Bender L, Widmann KM, Harpain F, et al · · 2021 · cited 8× · PMID 34768486 · DOI 10.3390/jcm10214965
Clinical effectiveness and safety of self-expandable implantable bulking agents for faecal incontinence: a systematic review.
Gassner L, Wild C, Walter M. · · 2022 · cited 5× · PMID 35978293 · DOI 10.1186/s12876-022-02441-4

Verify or expand the search:

Other recruiting trials for Faecal Incontinence

Currently open trials in the same condition.

NCT07126327 — Peristeen Light Explorative Clinical Investigation · NA · recruiting
NCT06143072 — CArE for OAsI Study: Care Pathways and Anorectal Evaluation for OASI Associated Incontinence · recruiting
NCT06601985 — Exploring the Effect of Colonic J-pouch in Anorectal Preservation Surgery for Ultra-low Rectal Cancer. · active not recruiting
NCT05245565 — Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer · recruiting
NCT04918329 — Functional Digestive Disorders Observatory · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04664868 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 11 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04664868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing